6505--Bupropion Tablets
ID: 36E79724R0029Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/325ffff29c614f4e92d913c89088eba2/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of Bupropion Hydrochloride tablets, aimed at supporting veterans and related entities through its Pharmaceutical Prime Vendor Programs. Offerors are required to submit pricing that includes a 0.5% Cost Recovery Fee and provide unique National Drug Code (NDC) numbers for their products, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and FDA regulations. This procurement is crucial for maintaining a reliable pharmaceutical supply for VA healthcare facilities, with an emphasis on participation from small and disadvantaged businesses. Interested parties can reach out to Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further details.

    Point(s) of Contact
    Andrew J CazaresContract Specialist
    Andrew.Cazares@va.gov
    Files
    Title
    Posted
    36E79724R0029_1.docx
    The Department of Veterans Affairs (VA) National Acquisition Center is preparing to issue a Request for Proposal (RFP) numbered 36E79724R0029 for the procurement of Bupropion Hydrochloride (HCL) Tablets. This procurement ensures a consistent supply of these medications for various federal institutions, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract will last one year with an option for four additional years. Offerors must provide unique product labels and National Drug Code (NDC) numbers for the items supplied. Expected annual usage indicates a need for over 158,000 bottles of Bupropion tablets in different dosages. The proposal’s electronic solicitation is scheduled for release around September 16, 2024, with a submission deadline of September 30, 2024. Interested participants must regularly check the SAM.gov website for updates, as no paper copies will be distributed. Andrew Cazares serves as the primary point of contact for inquiries related to this procurement process. The notice emphasizes the VA's commitment to uninterrupted access to necessary pharmaceuticals for veterans and other eligible entities.
    36E79724R0029.docx
    The document outlines a solicitation from the Department of Veterans Affairs (VA) for the procurement of Bupropion Hydrochloride tablets to serve veterans and related entities through the Pharmaceutical Prime Vendor (PPV) Programs. It specifies the required quantities for both the base year and four option years. Offerors must submit prices that include a 0.5% Cost Recovery Fee, alongside unique National Drug Code (NDC) numbers specific to their products. The solicitation details necessary compliance with the Drug Supply Chain Security Act (DSCSA) and mandates that all products comply with FDA regulations and Good Manufacturing Practices (cGMP). The document also emphasizes the need for offerors to provide Letters of Commitment from manufacturers if they are not the producers, as well as demonstrating compliance with Federal Acquisition Regulation (FAR) requirements related to contract submissions. Additionally, the structure includes sections on contract clauses, requirements for manufacturing facilities, product registration, packaging, and barcode labeling. This solicitation reflects the VA's commitment to ensuring reliable and compliant pharmaceutical supply for its healthcare facilities while promoting participation from small and disadvantaged businesses.
    Lifecycle
    Title
    Type
    6505--Bupropion Tablets
    Currently viewing
    Solicitation
    6505--Bupropion Tablets
    Presolicitation
    Similar Opportunities
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Prasugrel Hydrochloride (HCL) tablets in 5mg and 10mg 30 count bottles. The procurement aims to establish a reliable supply chain for these pharmaceutical products, which are critical for the healthcare of veterans and related agencies, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). Offerors must provide pricing for a base year and four optional one-year periods, demonstrate manufacturing and distribution capabilities, and adhere to stringent reporting and safety standards. Interested contractors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details regarding the solicitation process.
    6505--Abiraterone Acetate Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the supply of Abiraterone Acetate tablets, a pharmaceutical product critical for various government healthcare facilities, including the VA and DoD. The procurement aims to establish a reliable source through competitive contracting, requiring offerors to provide pricing for a base year and four option years, along with an NDC number for their products. Abiraterone Acetate is essential for treating specific cancers, underscoring the importance of ensuring consistent availability of this medication to support patient care. Interested vendors should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must comply with specific packaging, labeling, and manufacturing standards as outlined in the solicitation document.
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Zolmitriptan tablets, as outlined in solicitation number VA-25-00006129. This contract aims to establish a reliable source of pharmaceutical supplies for federal healthcare programs, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices as mandated by the FDA. The selected contractor will be responsible for providing competitive pricing for both the base year and four option years, ensuring that all products meet safety and regulatory standards. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details and to discuss submission requirements.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Norethindrone 5mg Tablets under solicitation number VA-25-00005551. This procurement falls under the Pharmaceutical Preparation Manufacturing industry, specifically categorized as drugs and biologicals, indicating the importance of these tablets in the healthcare services provided to veterans. Interested vendors should reach out to the primary contact, Contracting Officer Adrienne A Albachiara, via email at Adrienne.Albachiara@va.gov for further details regarding the submission process and any deadlines associated with this opportunity.
    R702--PBM Drug Pricing Database [VA-25-00000408]
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for a subscription service to access Pharmacy Average Wholesale Pricing (AWP) data, aimed at ensuring compliance with federal regulations regarding pharmacy agreements with third-party payers and pharmacy benefit managers. This service is critical for the VA to assess whether reimbursement rates proposed by PBMs meet federal requirements, thereby maximizing revenue streams while adhering to legal standards. The contract is set for one year, starting in December 2024, with an option for four additional years, and has an estimated budget of approximately $19.5 million. Interested vendors must submit their proposals by October 1, 2024, and can contact Contract Specialist Orangella Bittick at Orangella.Bittick@va.gov or (314) 894-6460 for further information.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    SPE2D220R0063 BUPROPION XL AMENDMENT 0002
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking BUPROPION XL. This procurement is for drugs and biologicals under PSC code 6505. The primary contact for this procurement is Catherine Gilbert (catherine.gilbert@dla.mil, 2157374778) and the secondary contact is Denise Taubman (denise.taubman@dla.mil, 2157376877). The notice includes Amendment 0002, which incorporates telecommunication clauses. The solicitation is not reopened and the closing date is not extended. BUPROPION XL is typically used for medical purposes.
    6505--Levothyroxine Tablets (VA-24-00084562)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking suppliers for Levothyroxine Tablets under the solicitation titled '6505--Levothyroxine Tablets (VA-24-00084562)'. This procurement aims to acquire pharmaceutical preparations, specifically Levothyroxine, which is critical for treating thyroid hormone deficiencies in veterans. The contract will fall under the NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and the PSC code 6505, indicating Drugs and Biologicals. Interested vendors can reach out to Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov for further details regarding the submission process and deadlines.
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.
    765-24-3-021-0910 -Hines CMOP MESALAMINE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking vendors to provide Mesalamine 800MG EC Tablets for the Hines CMOP facility under the solicitation RFQ 36C77024Q0404. Interested parties must submit their quotes by September 19, 2024, and ensure that all pharmaceuticals have a minimum one-year expiration from the delivery date, adhering to the Trade Agreements Act regulations. This procurement is crucial for maintaining the supply of essential medications to veterans, emphasizing compliance with federal regulations and the integrity of the pharmaceutical supply chain. Vendors are required to register in SAM.gov and submit a comprehensive solicitation package, including a signed SF1449 form, pricing schedule, and proof of a state wholesale distributor license. For further inquiries, contact Sarah Fry at sarah.fry2@va.gov or call 913-758-9935.